Download - Mongolia one day prevalence study
![Page 1: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/1.jpg)
One day prevalence study
Mongolia, January/February 2012
Walter Popp, University Clinics Essen, Germany
1
One day prevalence study
Mongolia, January/February 2012
Walter Popp, University Clinics Essen, Germany
![Page 2: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/2.jpg)
Prevalence study (cross-sectional/transverse)
Infections in all patients hospitalized at a given point in time are identified (pointprevalence) in the entire hospital, or on selected units.
Typically, a team of trained investigators visits every patient of the hospital on asingle day, reviewing medical and nursing charts, interviewing the clinicalstaff to identify infected patients, and collecting risk factor data. The outcomemeasure is a prevalence rate.
Performed ideally on a single day or week.They can show the magnitude of HAI, identify changing patterns of HAIs, define
target areas for intervention.
Incidence study (continuous/longitudinal)
Prospective identification of new infections (incidence surveillance) requiresmonitoring of all patients within a defined population for a specified timeperiod.
Patients are followed throughout their stay, and sometimes after discharge (e.g.post-discharge surveillance for surgical site infections).
This type of surveillance provides attack rates, infection ratio and incidence rates.It is more effective in detecting differences in infection rates, to follow trends,to link infections to risk factors, and for inter-hospital and inter-unitcomparisons.
2
Prevalence study (cross-sectional/transverse)
Infections in all patients hospitalized at a given point in time are identified (pointprevalence) in the entire hospital, or on selected units.
Typically, a team of trained investigators visits every patient of the hospital on asingle day, reviewing medical and nursing charts, interviewing the clinicalstaff to identify infected patients, and collecting risk factor data. The outcomemeasure is a prevalence rate.
Performed ideally on a single day or week.They can show the magnitude of HAI, identify changing patterns of HAIs, define
target areas for intervention.
Incidence study (continuous/longitudinal)
Prospective identification of new infections (incidence surveillance) requiresmonitoring of all patients within a defined population for a specified timeperiod.
Patients are followed throughout their stay, and sometimes after discharge (e.g.post-discharge surveillance for surgical site infections).
This type of surveillance provides attack rates, infection ratio and incidence rates.It is more effective in detecting differences in infection rates, to follow trends,to link infections to risk factors, and for inter-hospital and inter-unitcomparisons.
![Page 3: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/3.jpg)
3
![Page 4: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/4.jpg)
Continuous surveillance:Active, passive, or a combination of both.
Active surveillance:Daily visits to patient wards/care units to assess patients at-risk of HAI, e.g.,surgical site infection (SSI) or central line–associated bloodstream infection(CLABSI).It requires trained staff.
Passive surveillance:Reporting by individuals outside the infection control team (laboratory-basedsurveillance, extraction from medical records postdischarge, infection notificationby physicians or nurses) is of low sensitivity.Positive laboratory reports do not always indicate infection, and negative ones donot always mean infection is absent.
Case finding using active and passive surveillance by an IPC practitionerincreases correct detection of HAIs from approximately 25% to >85%.In continuous surveillance, only incidence cases of HAI should be reported.
4
Continuous surveillance:Active, passive, or a combination of both.
Active surveillance:Daily visits to patient wards/care units to assess patients at-risk of HAI, e.g.,surgical site infection (SSI) or central line–associated bloodstream infection(CLABSI).It requires trained staff.
Passive surveillance:Reporting by individuals outside the infection control team (laboratory-basedsurveillance, extraction from medical records postdischarge, infection notificationby physicians or nurses) is of low sensitivity.Positive laboratory reports do not always indicate infection, and negative ones donot always mean infection is absent.
Case finding using active and passive surveillance by an IPC practitionerincreases correct detection of HAIs from approximately 25% to >85%.In continuous surveillance, only incidence cases of HAI should be reported.
![Page 5: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/5.jpg)
Post-discharge surveillance
A common question of surveillance programmesis:Do you need to include post-dischargesurveillance in the surveillance plan?
5
![Page 6: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/6.jpg)
Figure 4.2 depicts a short prevalence survey of seven days.Six patients were surveyed, and two had an active infection:Patient-3 developed a new infection during the surveillance period andPatient-6 had an existing infection.Therefore, the number of infections (numerator) would be two for six(denominator) patients.Patient-5 acquired an infection which is not included because it appearedafter the last day of the survey.
6
![Page 7: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/7.jpg)
7
![Page 8: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/8.jpg)
Definitions for HAI
Definitions should distinguish between HAI and community-acquired infection (CAI).HAIs can be defined generally as “An infection occurring in apatient during the process of care in a hospital or other health-care facility which was not present or incubating at the time ofadmission. This includes infections acquired in the health-carefacility but appearing after discharge and also occupationalinfections among health-care workers of the facility”.
Cutt-off point 48 hours after admission is typically used todistinguish between HAI and CAI.
Well-established criteria for HAIs have been developed by theU.S. Centers for Disease Control and Prevention (CDC).
8
Definitions for HAI
Definitions should distinguish between HAI and community-acquired infection (CAI).HAIs can be defined generally as “An infection occurring in apatient during the process of care in a hospital or other health-care facility which was not present or incubating at the time ofadmission. This includes infections acquired in the health-carefacility but appearing after discharge and also occupationalinfections among health-care workers of the facility”.
Cutt-off point 48 hours after admission is typically used todistinguish between HAI and CAI.
Well-established criteria for HAIs have been developed by theU.S. Centers for Disease Control and Prevention (CDC).
![Page 9: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/9.jpg)
9
![Page 10: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/10.jpg)
10
![Page 11: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/11.jpg)
11
![Page 12: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/12.jpg)
Problems
Influence of the persons doing surveillance (standing/reputationin the hospital staff?)
Problem of small numbers in short periods (e.g. 3 months)
Problems of diagnosis:Sepsis: the more cases the more blood culturesPneumonia: who makes the x-ray diagnosis?Politics of antibiotics: more antibiotics less infections?Microbiologic confirmation of infections?
Numbers of indicator operations big enough?e.g. infection rate about 2 % in Germany
12
Problems
Influence of the persons doing surveillance (standing/reputationin the hospital staff?)
Problem of small numbers in short periods (e.g. 3 months)
Problems of diagnosis:Sepsis: the more cases the more blood culturesPneumonia: who makes the x-ray diagnosis?Politics of antibiotics: more antibiotics less infections?Microbiologic confirmation of infections?
Numbers of indicator operations big enough?e.g. infection rate about 2 % in Germany
![Page 13: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/13.jpg)
13
![Page 14: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/14.jpg)
14
![Page 15: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/15.jpg)
15
![Page 16: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/16.jpg)
16
![Page 17: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/17.jpg)
17
![Page 18: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/18.jpg)
18
![Page 19: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/19.jpg)
19
![Page 20: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/20.jpg)
20
![Page 21: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/21.jpg)
21
![Page 22: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/22.jpg)
22
![Page 23: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/23.jpg)
23
![Page 24: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/24.jpg)
24
![Page 25: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/25.jpg)
25
![Page 26: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/26.jpg)
26
![Page 27: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/27.jpg)
27
![Page 28: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/28.jpg)
28
![Page 29: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/29.jpg)
29
![Page 30: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/30.jpg)
30
![Page 31: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/31.jpg)
31
![Page 32: Mongolia one day prevalence study](https://reader033.vdocuments.net/reader033/viewer/2022052315/5560b147d8b42af93b8b4620/html5/thumbnails/32.jpg)
Thank you for your attention!
32